Epidemiologic Evidence for Multiple Sclerosis as an Infection.

Clinical Microbiology Reviews - United States
doi 10.1128/cmr.6.4.382
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Optimizing Therapy Early in Multiple Sclerosis: An Evidence-Based View

Multiple Sclerosis and Related Disorders
MedicineNeurology
2015English

Erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”

Seminars in Neurology
Neurology
2008English

Salivary IL-1ß as an Objective Measure for Fatigue in Multiple Sclerosis?

Frontiers in Neurology
Neurology
2018English

Ribotyping as an Epidemiologic Tool for Escherichia Coli

Epidemiology and Infection
EpidemiologyInfectious Diseases
1994English

Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis

New England Journal of Medicine
Medicine
2012English

Fingolimod (FTY720) as an Anti-Multiple Sclerosis Oral Ultimate Therapy

Biosciences Biotechnology Research Asia
BiotechnologyAgronomyCrop ScienceDrug Discovery
2015English

Secondarily Generalised, Partial Crises as an Expression of Multiple Sclerosis

Anales del Sistema Sanitario de Navarra
Medicine
2009English

Alemtuzumab: Evidence for Its Potential in Relapsing–remitting Multiple Sclerosis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2013English

Biotin for Multiple Sclerosis

Pharmacy Today
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy